JOHN FAGAN: Open Payments
NPI 1306904628 · RANCHO CUCAMONGA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,745 in 79 payments from 34 companies in 2025. Trend: 2023 $1,616 · 2024 $1,314 · 2025 $1,745
Food & beverage: $1,595Consulting: $150
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 8 | $181 |
| ABBVIE INC. | 11 | $150 |
| JAZZ PHARMACEUTICALS INC. | 1 | $150 |
| Otsuka America Pharmaceutical, Inc. | 4 | $99 |
| Exact Sciences Corporation | 5 | $98 |
| Corcept Therapeutics | 4 | $95 |
| Lilly USA, LLC | 4 | $84 |
| Novo Nordisk Inc | 3 | $72 |
| Amgen Inc. | 4 | $71 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $70 |
Products named: GEMTESA, XYWAV, REXULTI, Korlym, XIFAXAN, MOUNJARO, The Cologuard Plus Collection Kit, VOQUEZNA.
Industry payments across CA — which companies pay providers there.
